Sign in
4/A

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001209191-19-023074

Options or other derivatives

  • Chief Scientific Officer acquired 11,485 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ettenberg Seth Chief Scientific Officer 2019-03-25 Option exercise · Stock Option (Right to Buy) −11,485 329,145 D
Loading xslF345X03/doc4a.xml…